The Official Medicare Set Aside Blog And Information Resource

State-Imposed Restrictions on Gabapentin

Medicare Set-Aside Blog, MSAs, Rx/Pharmacy on January 8, 2020
Posted by Leah King, PharmD, JD, Independent Pharmacy Consultant

In recent years, we have seen a growing number of instances where federal law and state law are not in perfect alignment with regard to certain medications. As one example, we’ve seen a number of states pass laws allowing for the medical and/or recreational use of marijuana compounds even though marijuana is classified as a […] Continue

Department of Health and Human Services Issues New Opioid Guidelines

Medicare Set-Aside Blog, Opioids, Rx/Pharmacy on December 18, 2019
Posted by Leah King, PharmD, JD, Independent Pharmacy Consultant

This past July, CMS issued an educational piece that warned of the dangers associated with the concurrent use of opioids and benzodiazepines. You may have seen our blog on the CMS publication. If you missed that blog, you can read it here. In October, the Department of Health and Human Services (HHS) issued guidelines on […] Continue

Does Orphan Drug Status for Rofecoxib Open the Door for Increased Use?

Medicare Set-Aside Blog, Rx/Pharmacy on December 13, 2019
Posted by Leah King, PharmD, JD, Independent Pharmacy Consultant

Just over two years ago, the FDA granted orphan drug status to rofecoxib for the treatment of hemophilic arthropathy. Rofecoxib was previously marketed by Merck under the trade name of Vioxx and depending on your age, you may recall hearing about Vioxx in the news. Vioxx was initially approved by the FDA in 1999 for […] Continue

My Prescription Costs . . . How Much??

Medicare Set-Aside Blog, Rx/Pharmacy on December 2, 2019
Posted by Leah King, PharmD, JD, Independent Pharmacy Consultant

In recent years, a great deal of attention has been paid to the topic of drug prices and more specifically, how to control them. On a personal note, it’s likely that most of us have gone to the pharmacy to pick up a prescription and been surprised by the cost. On a professional note, in […] Continue

Behind the Counter Availability of Naloxone

Medicare Set-Aside Blog, Medicare Set-Asides, Opioids, Rx/Pharmacy on October 2, 2019
Posted by Leah King, PharmD, JD, Independent Pharmacy Consultant

One component of the FDA’s drug approval process is a designation of the drug as prescription only or over-the-counter (OTC). If a drug is initially approved as a prescription only medication, this doesn’t mean that the drug cannot later be approved for over-the-counter status. In order to facilitate this change, the drug manufacturer files a […] Continue